Edesa Biotech (EDSA) Misses Q2 EPS by 6c

Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
• Canaccord Reiterates Buy Rating on Achieve Life Sciences (ACHV)
• ROK Resources sells non-core Saskatchewan assets for $8 million